Endometriosis Trial, Recruiting NCT07603960 Sponsor: University of Edinburgh Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07603960
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women or people who were assigned female at birth
  • Aged 16 or over
  • Endometriosis confirmed by keyhole surgery or imaging within the last ten years
  • Pelvic pain that has lasted for more than six months
  • Willing to follow the treatment plan required by the trial
  • Willing to use effective contraception throughout the trial, if this applies
  • Willing and able to give informed consent to take part

Who may not be able to join:

  • People who are currently pregnant, breastfeeding, or actively trying to become pregnant
  • People who have gone through menopause (no periods for more than 12 months and not taking hormonal treatment to prevent periods, or who have had both ovaries removed)
  • People who have had their uterus and both ovaries removed (hysterectomy with bilateral oophorectomy)
  • People with Raynaud's Disease (a condition affecting blood flow to the extremities)
  • People currently receiving treatment for cancer
  • People with diabetes
  • People with a known underactive thyroid (hypothyroidism)
  • People with a pre-existing or current diagnosis of anaemia (low red blood cells or iron)
  • People with certain heart or blood vessel conditions, including severely high blood pressure, unstable chest pain, irregular heart rhythm, a heart attack or stroke within the last six months, peripheral artery disease, or a cardiac pacemaker (confirm with trial site)
  • People with acute kidney or urinary tract diseases
  • People with a condition called cryoglobulinemia (an immune system condition affecting the blood)
  • People with a history of blood clots in the veins or blocked arteries in the limbs
  • People with cold urticaria (a skin reaction triggered by cold temperatures)
  • People with livedo reticularis (a skin condition causing a mottled, net-like pattern)
  • People with open wounds, ulcers, or large-area bacterial or viral skin infections
  • People with a seizure disorder that is not well controlled
  • People with a known blood clotting disorder, such as von Willebrand disease or haemophilia
  • People with severe claustrophobia
  • People with an active infection or fever at the time of joining
  • People under the influence of alcohol or drugs
  • People showing signs or symptoms of a cold allergy
  • People with severe wasting or muscle-loss conditions
  • People with known Hepatitis B, Hepatitis C, or HIV — noted in the trial criteria as being due to postal restrictions on sending biological samples

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Edinburgh
Registry
ClinicalTrials.gov
Start date
9 April 2026
Est. completion
1 November 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Change in average pain over the preceding week measured by an 11-point Numerical Rating Scale (NRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov